By Sabela Ojea
West Pharmaceutical Services is buying back up to 550,000 shares on the open market or in privately negotiated transactions.
The company on Friday said that its board of directors on Monday approved the share repurchase program, expected to be completed by the end of next year.
West Pharmaceutical Services' previously authorized stock buyback program is expected to expire by the end of this year.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
December 13, 2024 16:23 ET (21:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.